• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 2
  3. Author

Online ISSN: 2515-8260

Volume9, Issue2

Comparison of intrathecal hyperbaric bupivacaine 0.5% with intrathecal hyperbaric bupivacaine 0.5% with low dose buprenorphine for post-operative analgesia in lower abdominal surgeries

    Dr. PB Banerjee, Dr. Kota Ramya

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 2, Pages 3036-3042

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Lower abdominal surgeries are usually performed under subarachnoid block, also called spinal anesthesia. The drug which is routinely used for spinal anesthesia is 0.5% hyperbaric Bupivacaine. Addition of adjuvants to the hyperbaric Bupivacaine helps in prolonging the duration of anesthesia and provides better and prolonged post-operative analgesia.
Materials and Methods: This study was done on 100 ASA 1 & 2 patients between 18 and 70 years who underwent various lower abdominal surgeries at our hospital. Patients were divided into two groups, Group I were given 0.5% hyperbaric Bupivacaine and Group II were given 0.5% hyperbaric Bupivacaine along with 60 mcg Buprenorphine in the intrathecal space.
Results: The onset of sensory blockade was significantly earlier in patients in group I, while the duration of analgesia was significantly longer in group II, 426 ± 41.17 minutes as compared to 203.49 ± 41.35 minutes in group I. More than 80% patients in group II had mild post-operative pain only after 8 hours, whereas patients in group I started having moderate to severe pain after 4 hours. About 15% patients in group II experienced nausea, vomiting and drowsiness.
Conclusion: Buprenorphine is an effective adjuvant to provide prolonged post-operative analgesia with minimal hemodynamic changes and minor side effects
Keywords:
    Buprenorphine Bupivacaine sensory blockade abdominal surgeries duration of analgesia
  • PDF (252 K)
  • XML
(2023). Comparison of intrathecal hyperbaric bupivacaine 0.5% with intrathecal hyperbaric bupivacaine 0.5% with low dose buprenorphine for post-operative analgesia in lower abdominal surgeries. European Journal of Molecular & Clinical Medicine, 9(2), 3036-3042.
Dr. PB Banerjee, Dr. Kota Ramya. "Comparison of intrathecal hyperbaric bupivacaine 0.5% with intrathecal hyperbaric bupivacaine 0.5% with low dose buprenorphine for post-operative analgesia in lower abdominal surgeries". European Journal of Molecular & Clinical Medicine, 9, 2, 2023, 3036-3042.
(2023). 'Comparison of intrathecal hyperbaric bupivacaine 0.5% with intrathecal hyperbaric bupivacaine 0.5% with low dose buprenorphine for post-operative analgesia in lower abdominal surgeries', European Journal of Molecular & Clinical Medicine, 9(2), pp. 3036-3042.
Comparison of intrathecal hyperbaric bupivacaine 0.5% with intrathecal hyperbaric bupivacaine 0.5% with low dose buprenorphine for post-operative analgesia in lower abdominal surgeries. European Journal of Molecular & Clinical Medicine, 2023; 9(2): 3036-3042.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 7
  • PDF Download: 11
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus